MassIVE MSV000092363

Partial Public

GNPS - RdRp MALDI Data Set - 2022, Slavish/Rimmer

Description

Chemical scaffold recycling: Structure-guided conversion of an HIV integrase inhibitor into a potent influenza virus RNA-dependent RNA polymerase inhibitor designed to minimize resistance potential Eur J Med Chem. 2023 Feb 5;247:115035. doi: 10.1016/j.ejmech.2022.115035. Epub 2022 Dec 22. Slavish, Jake et al. The enzymatic activity of PAN endonuclease in the presence of inhibitors was measured using a MALDI-FTICR-MS-based functional assay. An ECHO 650 acoustic dispenser plate reformat protocol (Labcyte) was used to make 16-point dose responses of each compound (67.5 nL, from 45 uM to 0.8 pM) in 384-well plate format (Greiner Bio-One). The compounds were pre-incubated for 1 h with 10 uL of the enzyme assay mix; 300 nM PAN endonuclease, 5 mM manganese chloride (Aldrich), 20 mM 2-mercaptoethanol (Calbiochem) in 10 mM Tris pH 8.0 (Fisher Scientific). The reaction was initiated by the addition of 10 uL of RNA (Integrated DNA Technologies) to a final concentration of 50 uM. The plate was incubated at room temperature for 90 min before being quenched with the addition of 10% formic acid (EMD Millipore Corp.). Two microliters of each reaction were mixed with 8 uL of 40 mg/mL 3-hydroxypicolinic acid (Sigma-Aldrich) in 70% acetonitrile (Fisher Scientific) containing 10 mg/ml ammonium citrate (Fisher Scientific), manually spotted on a 384 Anchorchip MALDI target (Bruker Daltonics), and let dry at room temperature. The experiments were performed on a 7-T SolariX XR FT-ICR Mass Spectrometer (Bruker Daltonics) in MALDI negative mode using ftmsControl v2.3. The spectrometer instrument method was developed specifically to improve its dynamic range for substrate/product RNA with minimal sample preparation. Thus, with a mass range of 150 to 5000 m/z, signal from a minimum 10 transients were accumulated and each transient analyzing ions produced from 300 MALDI laser shots at a 500 Hz frequency. Other FTMS settings were as follows: sweep excitation power of 44%, excitation waveform calculation version 2, Time of Flight of 0.002 s, Q1 mass of 300 m/z, ion accumulation time of 0.025 s, laser power 40 lp. The readout for this assay was the disappearance of a single-stranded, 17-mer RNA substrate (5'-UCUCUAGCAGUGGCGCC -3'; m/z = 2687.3 for doubly-charged species) and appearance of the 7-mer hydrolyzed product (5'-UCUCUAG-3' m/z = 2139.6 for singly-charged species). Five assay replicates across three days were performed with two instrument replicates per assay. The highest 2500 local maxima with an absolute intensity threshold of 100,000 were extracted, and those within +/- 0.1 m/z of target m/z were used to calculate product and substrate intensity. Enzyme turnover (T) was calculated as a ratio of product intensity (I) over total intensity of substrate plus product (TRdRp = I2139.6/I2687.3 + I2139.6). Peak extraction and data analysis were performed in R using the RStudio IDE [59,60]. Z-prime was calculated for each individual FTMS target and targets with a resulting Z-prime below 0 were eliminated. FTMS replicates were then combined and Z-prime for each assay replicate was calculated (Table 6). Turnover values were normalized to negative controls and dose-response curves were fit to a four-parameter log-logistic model using non-linear least-squares optimization. Resulting fits were plotted using the ggplot2 visualization package. R code is available on request. [doi:10.25345/C52B8VN8B] [dataset license: CC0 1.0 Universal (CC0 1.0)]

Keywords: Biochemical ; High-Throughput ; RNA ; MALDI ; RdRp ; Drug Screen

Contact

Principal Investigators:
(in alphabetical order)
Zoran Rankovic, St. Jude Children's Research Hospital, USA
Submitting User: marimmer

Publications

Slavish PJ, Cuypers MG, Rimmer MA, Abdolvahabi A, Jeevan T, Kumar G, Jarusiewicz JA, Vaithiyalingam S, Jones JC, Bowling JJ, Price JE, DuBois RM, Min J, Webby RJ, Rankovic Z, White SW.
Chemical scaffold recycling: Structure-guided conversion of an HIV integrase inhibitor into a potent influenza virus RNA-dependent RNA polymerase inhibitor designed to minimize resistance potential.
Eur J Med Chem. Epub 2022 Dec 22.

Number of Files:
Total Size:
Spectra:
Subscribers:
 
Owner Reanalyses
Experimental Design
    Conditions:
    Biological Replicates:
    Technical Replicates:
 
Identification Results
    Proteins (Human, Remapped):
    Proteins (Reported):
    Peptides:
    Variant Peptides:
    PSMs:
 
Quantification Results
    Differential Proteins:
    Quantified Proteins:
 
Browse Dataset Files
Browse Metadata
 
FTP Download Link (click to copy):

- Dataset Reanalyses


+ Dataset History


GNPS content goes here (MSV000092363 [task=37bae135ec6044478358b9ffef4a8d9f])
Click here to queue conversion of this dataset's submitted spectrum files to open formats (e.g. mzML). This process may take some time.

When complete, the converted files will be available in the "ccms_peak" subdirectory of the dataset's FTP space (accessible via the "FTP Download" link to the right).
Number of distinct conditions across all analyses (original submission and reanalyses) associated with this dataset.

Distinct condition labels are counted across all files submitted in the "Metadata" category having a "Condition" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct biological replicates across all analyses (original submission and reanalyses) associated with this dataset.

Distinct replicate labels are counted across all files submitted in the "Metadata" category having a "BioReplicate" or "Replicate" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct technical replicates across all analyses (original submission and reanalyses) associated with this dataset.

The technical replicate count is defined as the maximum number of times any one distinct combination of condition and biological replicate was analyzed across all files submitted in the "Metadata" category. In the case of fractionated experiments, only the first fraction is considered.

"N/A" means no results of this type were submitted.
Originally identified proteins that were automatically remapped by MassIVE to proteins in the SwissProt human reference database.

"N/A" means no results of this type were submitted.
Number of distinct protein accessions reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct unmodified peptide sequences reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct peptide sequences (including modified variants or peptidoforms) reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Total number of peptide-spectrum matches (i.e. spectrum identifications) reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct proteins quantified across all analyses (original submission and reanalyses) associated with this dataset.

Distinct protein accessions are counted across all files submitted in the "Statistical Analysis of Quantified Analytes" category having a "Protein" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct proteins found to be differentially abundant in at least one comparison across all analyses (original submission and reanalyses) associated with this dataset.

A protein is differentially abundant if its change in abundance across conditions is found to be statistically significant with an adjusted p-value <= 0.05 and lists no issues associated with statistical tests for differential abundance.

Distinct protein accessions are counted across all files submitted in the "Statistical Analysis of Quantified Analytes" category having a "Protein" column in this dataset.

"N/A" means no results of this type were submitted.
This dataset may not contain all raw spectra data as originally deposited in PRIDE. It has been imported to MassIVE for reanalysis purposes, so its spectra data here may consist solely of processed peak lists suitable for reanalysis with most software.